​

Funding Round

Series D - Pear Therapeutics

Series D - Pear Therapeutics

Investment Firm

Overview

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Announced Date

Dec 08, 2020

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

9

Investor Name
Participant InvestorJazz Venture Partners
Participant InvestorEDBI
Participant InvestorArboretum Ventures
Participant InvestorNovartis
Participant InvestorPilot House Ventures

Round Details and Background

Pear Therapeutics raised $80000000 on 2020-12-08 in Series D

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 07, 2020
Debt Financing - Pear Therapeutics
1-50.0M
Dec 06, 2021
Post-IPO Equity - Pear Therapeutics
17-125.0M
Feb 03, 2016
Series A - Pear Therapeutics
5-20.0M
Mar 19, 2015
Venture Round - Pear Therapeutics
1-undefined

Recent Activity

There is no recent news or activity for this profile.